Navigation Links
Nephrologists summarize new renal research during public policy news briefing at Renal Week
Date:10/29/2007

Renal experts will summarize important new research on the topics of cardiovascular risk in chronic kidney disease, consequences of acute kidney injury, racial and ethnic disparities of kidney disease, and anemia management in kidney disease patients, being presented during the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco at a policy-centered news briefing on Saturday, November 3.

We hope that by highlighting significant research that could directly impact public health in America, we can ultimately improve health outcomes, said Jonathan Himmelfarb, MD of Maine Medical Center, Chair of ASNs Public Policy Board and moderator of the briefing.

Following a brief introduction by Dr. Himmelfarb, Mark J. Sarnak, MD, FASN of Tufts-New England Medical Center will discuss the link between chronic kidney disease (CKD) and cardiovascular disease (CVD) in his briefing presentation, The CKD - CVD Connection. Chi-yuan Hsu, MD, MS of University of California, San Francisco will address The Consequences of Acute Kidney Injury. The third topic, Race, Ethnicity in Outcomes of Patients with Kidney Disease (Health Disparities) will be presented by Neil R. Powe, MD, MPH, MBA, FASN of the Johns Hopkins University School of Medicine. Lynda A. Szczech, MD, MSCE, FASN of Duke University Medical Center will conclude the briefing with a discussion on The Treatment of Anemia in Kidney Disease.

The Public Policy News Briefing will take place on Saturday, November 3, 2007 from 12:15 pm to 1:15 pm in Room 236 of the Moscone Center South in San Francisco.


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-558-8423
American Society of Nephrology
Source:Eurekalert

Page: 1

Related medicine news :

1. Nephrologists Reassess Disaster Response Strategies
2. Renal problem alleviated
3. Increase in renal problems
4. Effect of drug on Renal Cancer
5. Renal problem increased
6. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
7. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
8. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
9. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
10. Clinical Renal Trails Do Not Have Sufficient Women Participants
11. Adrenal Suppression not predicted by inhaled corticosteroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology: